[1]宋 丹,郭 磊,李 静,等.DSA导引下经皮硬化治疗儿童阴茎区静脉畸形的效果和安全性[J].介入放射学杂志,2021,30(01):18-21.
 SONG Dan,GUO Lei,LI Jing,et al.DSA- guided percutaneous sclerotherapy for venous malformations at penile area in children: clinical effect and safety[J].journal interventional radiology,2021,30(01):18-21.
点击复制

DSA导引下经皮硬化治疗儿童阴茎区静脉畸形的效果和安全性()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年01
页码:
18-21
栏目:
血管介入
出版日期:
2021-01-25

文章信息/Info

Title:
DSA- guided percutaneous sclerotherapy for venous malformations at penile area in children: clinical effect and safety
作者:
宋 丹 郭 磊 李 静 王 亮 吴长华 张 鑫
Author(s):
SONG Dan GUO Lei LI Jing WANG Liang WU Changhua ZHANG Xin.
Department of Vascular Anomalies and Interventional Radiology, Qilu Children’s Hospital of Shandong University, Jinan, Shandong Province 250022, China
关键词:
【关键词】 硬化治疗 阴茎 儿童 静脉畸形
文献标志码:
A
摘要:
【摘要】 目的 探讨DSA导引下经皮硬化治疗儿童阴茎区静脉畸形的效果和安全性。方法 回顾性分析2016年1月至2017年6月山东大学齐鲁儿童医院采用经皮穿刺硬化治疗的11例阴茎区静脉畸形患儿临床资料。DSA透视下行局部静脉造影,判断瘤巢形态、范围和引流静脉回流情况。根据造影流速情况选择硬化剂(平阳霉素或聚多卡醇),DSA监视下经皮注射治疗。术后1个月复查MRI,显示仍有残留病灶予重复治疗。每次治疗后记录不良反应,随访评价疗效。结果 11例患儿14处病灶共接受32次硬化治疗,平均(2.5±1.0)次/例。随访24个月,6例治愈,3例症状明显缓解,2例部分缓解,均无复发或进展。所有患儿均未出现溃破、出血、感染及功能障碍等严重并发症。结论 DSA引导经皮硬化治疗儿童阴茎区静脉畸形安全有效,不影响阴茎外观和功能,值得临床推广。

参考文献/References:

[1] Bai N, Chen YZ, Fu YJ, et al. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 con- secutive patients[J]. J Clin Pharm Ther, 2014, 39: 521- 526.
[2] Lee BB, Baumgartner I, Berlien P, et al. Diagnosis and treatment of venous malformations. consensus document of the International Union of Phlebology(IUP): updated- 2013[J]. Int Angiol, 2015, 34: 97- 149.
[3] Rabe E, Pannier F. Sclerotherapy in venous malformation[J]. Phlebology, 2013, 28(Suppl 1): 188- 191.
[4] 张文显,李芳芳,杨伊帆,等. 无水乙醇+聚桂醇泡沫硬化+平阳霉素+弹力绷带联合治疗儿童静脉畸形的临床效果[J]. 中华介入放射学电子杂志, 2017, 5:227- 230.
[5] 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形诊断和治疗指南(2016版)[J]. 组织工程与重建外科杂志, 2016, 12:63- 93.
[6] McCafferty I. Management of low- flow vascular malformations: clinical presentation, classification, patient selection, imaging and treatment[J]. Cardiovasc Intervent Radiol, 2015, 38: 1082- 1104.
[7] Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins[J]. Dermatol Surg, 2001, 27: 58- 60.
[8] Murakami T, Ogata D, Miyano K, et al. An enlarged intramuscular venous malformation in the femoral region successfully treated with complete resection[J]. Int J Surg Case Rep, 2016, 21: 83- 86.
[9] Aboelatta YA, Nagy E, Shaker M, et al. Venous malformations of the head and neck: a diagnostic approach and a proposed mana- gement approach based on clinical, radiological, and histopa- thology findings[J]. Head Neck, 2014, 36: 1052- 1057.
[10] 牛传强,姜 华,周少毅,等. 泡沫硬化疗法治疗口咽部静脉畸形的效果分析[J]. 中华耳鼻咽喉头颈外科杂志, 2018, 53:209- 213.
[11] 李国文,古善智,黄满平,等. 聚桂醇泡沫硬化剂治疗静脉畸形效果与安全性评价[J]. 介入放射学杂志, 2018, 27:680- 684.
[12] Cabrera J, Cabrera J Jr, Garcia- Olmedo MA, et al. Treatment of venous malformations with sclerosant in microfoam form[J]. Arch Dermatol, 2003, 139: 1409- 1416.
[13] Xue L, Cao RY, Xu DP, et al. Percutaneous treatment of large venous malformations in the oral and maxillofacial regions using electrochemical therapy combined with pingyangmycin[J]. J Oral Maxillofac Surg, 2015, 73: 1384- 1391.
[14] 翟 军,翟晓东. 平阳霉素联合地塞米松治疗口腔颌面颈部静脉畸形[J]. 中华整形外科杂志, 2012, 28:168- 171.
[15] 高 阳,陈 辉,金云波, 等. 常用硬化剂治疗静脉畸形导致神经损伤的回顾性研究[J]. 组织工程与重建外科杂志, 2016, 12:222- 226.
[16] Steiner F, Fitzjohn T, Tan ST. Ethanol sclerotherapy for venous malformation[J]. ANZ J Surg, 2016, 86: 790- 795.
[17] 吴经纬. 平阳霉素联合地塞米松注射治疗口腔颌面颈部静脉畸形的临床效果评价[J]. 中国继续医学教育, 2016, 8:157- 158.
[18] 蒋贻洲,申 刚,刘 浪,等. 儿童眼眶内静脉畸形介入硬化疗法的疗效和安全性[J]. 中华放射学杂志, 2015, 49:469- 472.
[19] 牛传强,李海波,刘 浪,等. 经皮硬化疗法治疗手部静脉畸形37例[J]. 介入放射学杂志, 2018, 27:832- 835.
[20] 李海波,李小梅,周少毅,等. 数字减影血管造影引导下硬化治疗四肢肌肉间静脉畸形的疗效分析[J]. 中华小儿外科杂志, 2019, 40: 925- 929.
[21] Garg S, Kumar S, Singh YB. Intralesional radiofrequency in venous malformations[J]. Br J Oral Maxillofac Surg, 2015, 53: 213- 216.

备注/Memo

备注/Memo:
(收稿日期:2019- 11- 11)
(本文编辑:边 佶)
更新日期/Last Update: 2021-01-25